« Previous
Next »
The American Journal of Medicine
Volume 121, Issue 5
, Pages 385-386
, May 2008
Pseudocyanosis: Drug-Induced Skin Hyperpigmentation Can Mimic Cyanosis
References
- . Respiratory diseases: Cyanosis. In: Tintinalli JE, Kelen GD, Stapczynski JS editor. Emergency Medicine: A Comprehensive Study Guide. 6th edn.. New York, NY: McGraw-Hill, Medical Publishing Division; 2004;p. 443–444
- Harrison's Principles of Internal Medicine. 16th edn.. New York, NY: McGraw-Hill, Medical Publication Division; 2005;
- . Guest editorial: celebrating the 50th anniversary of the introduction of chlorpromazine in North America and the advent of the psychopharmacology revolution. Ann Clin Psychiatry. 2005;17:109–111
- . Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy. Can Med Assoc J. 1964;90:663–665
- Side effects of long-term amiodarone therapy. Circulation. 1983;67:45–51
- . Minocycline-induced pigmentation (Incidence, prevention and management). Drug Saf. 1998;18:431–440
- . Drug induced changes in pigmentation. Br J Dermatol. 1973;89:105–112
- . Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol. 1992;31:458–466
- . A case of argyria after colloidal silver ingestion. J Cutan Pathol. 2006;33:809–811
- . Drug-induced skin pigmentation (Epidemiology, diagnosis and treatment). Am J Clin Dermatol. 2001;2:253–262
- Chrysiasis revisited: a clinical and pathological study. Br J Dermatol. 1995;133:671–678
Thomas J. Marrie, MD, Section Editor
PII: S0002-9343(08)00078-8
doi: 10.1016/j.amjmed.2008.01.029
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 121, Issue 5
, Pages 385-386
, May 2008

